Nojima et al., Fig. S1

1
Nojima et al., Fig. S1
2
Nojima et al., Fig. S1
3
Nojima et al., Fig. S2
4
Nojima et al., Fig. S3
C
A
PML-II-RFP
E6-7b-RFP
I (0.01)
I (0.05)
Uninfected
U
U
anti-RFP
anti-tubulin a
1
2
3
4
B
Venus-HSV-2- infected (0.01MOI)
1
1
0.8
0.85
0.6
Fold of RFP expression
0.4
Venus-HSV-2- infected (0.05MOI)
0.2
0.25
0
U
I (0.01)
I (0.05)
5
Nojima et al., Fig. S4
Myc-vector
Myc-ICP27
Myc-UL12
Myc-UL18
Myc-UL3
-
anti-RFP
anti-GAPDH
0
1
0.06
RFP/GAPDH
1.18
0.84
1.06
6
Nojima et al., Fig. S5
7
Nojima et al., Fig. S6
8
Nojima et al., Fig. S7
9
Nojima et al., Table S1
10
Nojima et al., Table S2